Omid Khorram to Middle Aged
This is a "connection" page, showing publications Omid Khorram has written about Middle Aged.
Connection Strength
1.704
-
Comparative Analysis of Differentially Expressed Long Non-Coding RNA in Pre- and Postmenopausal Fibroids. Int J Mol Sci. 2025 Jul 16; 26(14).
Score: 0.171
-
Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas. Int J Mol Sci. 2025 Feb 16; 26(4).
Score: 0.166
-
The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis. Int J Mol Sci. 2024 Oct 27; 25(21).
Score: 0.162
-
The immune landscape of uterine fibroids as determined by mass cytometry. F S Sci. 2024 Aug; 5(3):272-282.
Score: 0.159
-
Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family. Endocrinology. 2021 11 01; 162(11).
Score: 0.132
-
Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Fertil Steril. 2021 01; 115(1):238-247.
Score: 0.123
-
Cross-talk between miR-29c and transforming growth factor-ß3 is mediated by an epigenetic mechanism in leiomyoma. Fertil Steril. 2019 12; 112(6):1180-1189.
Score: 0.116
-
Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma. Fertil Steril. 2018 05; 109(5):919-929.
Score: 0.104
-
Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma. Reprod Sci. 2019 02; 26(2):250-258.
Score: 0.103
-
Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing. Reprod Sci. 2018 02; 25(2):246-255.
Score: 0.097
-
Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma. Fertil Steril. 2016 Jan; 105(1):236-45.e1.
Score: 0.087
-
miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. PLoS One. 2014; 9(4):e95370.
Score: 0.078
-
Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions. Mol Hum Reprod. 2002 Jan; 8(1):75-80.
Score: 0.033
-
The influence of aging and sex hormones on expression of growth hormone-releasing hormone in the human immune system. J Clin Endocrinol Metab. 2001 Jul; 86(7):3157-61.
Score: 0.032
-
Endometrial and myometrial expression of nitric oxide synthase isoforms in pre- and postmenopausal women. J Clin Endocrinol Metab. 1999 Jun; 84(6):2226-32.
Score: 0.028
-
Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women. J Clin Endocrinol Metab. 1997 Nov; 82(11):3590-6.
Score: 0.025
-
Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. J Clin Endocrinol Metab. 1997 May; 82(5):1472-9.
Score: 0.024
-
Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci. 1997 Jan; 52(1):M1-7.
Score: 0.024
-
Replacement of DHEA in aging men and women. Potential remedial effects. Ann N Y Acad Sci. 1995 Dec 29; 774:128-42.
Score: 0.022
-
Testosterone dose-response relationships in hysterectomized women with or without oophorectomy: effects on sexual function, body composition, muscle performance and physical function in a randomized trial. Menopause. 2014 Jun; 21(6):612-23.
Score: 0.020